Evaluation of 793/B-like and Mass-like vaccine strain kinetics in experimental and field conditions by real-Time RT-PCR quantification
Συγγραφέας
Tucciarone C.M., Franzo G., Berto G., Drigo M., Ramon G., Koutoulis K.C., Catelli E., Cecchinato M.Ημερομηνία
2018Γλώσσα
en
Λέξη-κλειδί
Επιτομή
Infectious bronchitis virus (IBV) is a great economic burden both for productive losses and costs of the control strategies. Many different vaccination protocols are applied in the same region and even in consecutive cycles on the same farm in order to find the perfect balance between costs and benefits. In Northern Italy, the usual second vaccination is more and more often moved up to the chick's first d of life. The second strain administration together with the common Mass priming by spray at the hatchery allows saving money and time and reducing animal stress. The present work compared the different vaccine strains (Mass-like or B48, and 1/96) kinetics both in field conditions and in a 21-day-long experimental trial in broilers, monitoring the viral replication by upper respiratory tract swabbing and vaccine specific real time reverse transcription PCR (RT-PCR) quantification. In both field and experimental conditions, titers for all the vaccines showed an increasing trend in the first 2 wk and then a decrease, though still remaining detectable during the whole monitored period. IBV field strain and avian Metapneumovirus (aMPV) presence also was also investigated by RT-PCR and sequencing, and by multiplex real-Time RT-PCR, respectively, revealing a consistency in the pathogen introduction timing at around 30 d, in correspondence with the vaccine titer's main decrease. These findings suggest the need for an accurate knowledge of live vaccine kinetics, whose replication can compete with the other pathogen one, providing additional protection to be added to what is conferred by the adaptive immune response.
Collections
Related items
Showing items related by title, author, creator and subject.
-
Development of a multiplex RT-PCR assay for the identification of recombination types at different genomic regions of vaccine-derived polioviruses
Dimitriou T.G., Kyriakopoulou Z., Tsakogiannis D., Fikatas A., Gartzonika C., Levidiotou-Stefanou S., Markoulatos P. (2016)Polioviruses (PVs) are the causal agents of acute paralytic poliomyelitis. Since the 1960s, poliomyelitis has been effectively controlled by the use of two vaccines containing all three serotypes of PVs, the inactivated ... -
Influenza virus genotypes circulating in central greece during 2012-2014 and vaccine strain match
Plakokefalos E., Vontas A., Florou Z., Valiakos G., Georgantza K., Sarrou S., Labronikou M., Gramoustianou E., Peteinaki E., Markoulatos P., Minas A., Krikelis V., Noulas A., Manouras A. (2015)During the period 2012-2014 in central Greece, influenza A(H1N1), A(H3N2) and B virus genotypes were detected and isolated from individuals with influenza illness. Influenza A(H1N1) and A (H3N2) viruses were the dominant ... -
Efficacy of an AS03 A-adjuvanted split H5N1 influenza vaccine against an antigenically distinct low pathogenic H5N1 virus in pigs
De Vleeschauwer, A. R.; Baras, B.; Kyriakis, C. S.; Jacob, V.; Planty, C.; Giannini, S. L.; Mossman, S.; Van Reeth, K. (2012)We used the pig model of influenza to examine the efficacy of an AS03 A-adjuvanted split H5N1 (A/Indonesia/05/2005) vaccine against challenge with a low pathogenic (LP) H5N1 avian influenza (AI) virus (duck/Minnesota/1525/1981) ...

